Hydrastine

Hydrastine is an isoquinoline alkaloid found in goldenseal root that has been studied primarily for its chemical properties rather than therapeutic effects. No clinical trials have documented health benefits in humans, with evidence limited to traditional use contexts only.

Origin & History

Hydrastine is an isoquinoline alkaloid isolated from the roots and rhizomes of Hydrastis canadensis L. (goldenseal), a perennial herb native to North America. It has the molecular formula C₂₁H₂₁NO₆ and exists naturally as the levorotatory β-hydrastine form, extracted alongside other alkaloids like berberine via solvent methods.

Historical & Cultural Context

Hydrastine occurs in Hydrastis canadensis (goldenseal), historically used in Native American traditional medicine. However, specific traditional uses for hydrastine versus other goldenseal alkaloids like berberine are not documented in available sources.

Health Benefits

• No clinical health benefits documented - no human trials identified in available research
• Traditional use context only through goldenseal preparations (evidence quality: traditional only)
• Chemical properties studied but no pharmacological effects documented (evidence quality: none)
• Safety profile not established through clinical research (evidence quality: insufficient)
• Mechanism of action unknown - no receptor or enzyme interactions identified (evidence quality: none)

How It Works

Hydrastine exhibits weak antimicrobial activity through interaction with bacterial cell membrane components, though specific receptor targets remain poorly characterized. The compound may influence calcium channel activity and smooth muscle contraction in laboratory studies. However, these mechanisms have not been validated in human clinical research or shown to produce therapeutic effects.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on hydrastine were identified in the available research. The compound has been studied primarily for its chemical properties rather than clinical applications, with goldenseal (containing 1-4% hydrastine) nominated for toxicity evaluation but no specific trial data available.

Clinical Summary

No randomized controlled trials or clinical studies have evaluated hydrastine's health effects in humans. Available research consists primarily of in vitro chemical analysis and traditional use documentation through goldenseal preparations. Laboratory studies have examined antimicrobial properties but failed to demonstrate clinically relevant potency. The evidence base remains insufficient to support any health claims for this alkaloid.

Nutritional Profile

Hydrastine is an isoquinoline alkaloid (molecular formula C₂₁H₂₁NO₆, MW ~383.4 g/mol) found primarily in goldenseal (Hydrastis canadensis) root, typically comprising 1.5–4% of dried root weight alongside berberine (~2–6%) and canadine. It is not a nutrient and has no macronutrient, vitamin, or mineral content. As a bioactive alkaloid, it undergoes hepatic metabolism and has limited oral bioavailability due to first-pass effects. It exists as two diastereomers (α-hydrastine and β-hydrastine), with β-hydrastine being the predominant natural form. The compound is poorly water-soluble but soluble in ethanol and chloroform. No established RDA, tolerable upper intake, or standardized dosing exists. It should be regarded strictly as a phytochemical of research interest, not a nutritional compound.

Preparation & Dosage

No clinically studied dosage ranges for hydrastine are available. The compound typically comprises 1-4% of goldenseal root extracts, but no human dosing data from trials exists. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Hydrastine naturally co-occurs with berberine and canadine in goldenseal root, and these three isoquinoline alkaloids may have complementary mechanisms—berberine targets NF-κB and AMPK pathways while hydrastine may contribute vasoconstrictive and smooth-muscle effects, potentially enhancing the overall antimicrobial and anti-inflammatory profile of whole goldenseal extracts. Echinacea purpurea alkylamides (particularly isobutylamides from Echinacea) are traditionally paired with goldenseal alkaloids in immune-support formulations, as the immunostimulatory action of echinacea may complement the antimicrobial alkaloid activity. Additionally, piperine (5–10 mg from black pepper extract) may enhance the oral bioavailability of hydrastine and co-occurring berberine by inhibiting CYP3A4 and P-glycoprotein efflux, similar to its well-documented effect of increasing berberine plasma concentrations by approximately 2-fold. Note: These synergies are theoretical or based on traditional formulation practices, not validated in clinical trials specific to isolated hydrastine.

Safety & Interactions

Safety data for isolated hydrastine is extremely limited due to lack of human studies. Potential concerns may mirror those of goldenseal, including possible interactions with cytochrome P450 enzymes and blood pressure medications. High doses may cause gastrointestinal irritation or cardiovascular effects based on alkaloid class properties. Pregnant and breastfeeding women should avoid due to insufficient safety data.